Volume 133, Issue 1, Pages (July 2007)

Slides:

Advertisements

Similar presentations

Recombinant human interleukin 10 in the treatment of patients with mild to moderately active Crohn's disease Richard N. Fedorak, *, Alfred Gangl, ‡, Charles.

Advertisements

Antibodies to CBir1 Flagellin Define a Unique Response That Is Associated Independently With Complicated Crohn’s Disease Stephan R. Targan, Carol J. Landers,

Volume 137, Issue 4, Pages (October 2009)

Volume 150, Issue 2, Pages (February 2016)

Guillaume Bouguen, Barrett G. Levesque, Brian G

Volume 120, Issue 4, Pages (March 2001)

Volume 138, Issue 2, Pages (February 2010)

Certolizumab Pegol in Patients With Moderate to Severe Crohn's Disease and Secondary Failure to Infliximab William J. Sandborn, Maria T. Abreu, Geert.

Huiqin He, Zhinong Jiang, Leimin Sun Gastroenterology

Millie D. Long, Bruce E. Sands

Abatacept for Crohn's Disease and Ulcerative Colitis

Volume 135, Issue 4, Pages (October 2008)

Covering the Cover Gastroenterology

Covering the Cover Gastroenterology

Volume 150, Issue 2, Pages (February 2016)

Ira J. Fox, Stephen C. Strom Gastroenterology

Volume 154, Issue 1, Pages e6 (January 2018)

Gastroenterology 2011–2016: Looking Back and Forward

Laurent Peyrin-Biroulet, Julián Panés, William J

Evidence for Life Before Inflammatory Bowel Disease

Volume 137, Issue 2, Pages (August 2009)

Unusual Case of an Upset Stomach

Volume 135, Issue 5, Pages (November 2008)

A Historical Perspective on Clinical Advances in Pancreatic Diseases

Volume 150, Issue 4, Pages (April 2016)

Challenges to the Therapeutic Pipeline for Irritable Bowel Syndrome: End Points and Regulatory Hurdles Michael Camilleri, Lin Chang Gastroenterology

Volume 130, Issue 2, Pages (February 2006)

Volume 155, Issue 1, Pages (July 2018)

Hepatitis C and Hepatocellular Carcinoma: Grist for the Mill

Volume 147, Issue 3, Pages e3 (September 2014)

AGA Clinical Practice Update on Functional Gastrointestinal Symptoms in Patients With Inflammatory Bowel Disease: Expert Review Jean-Frederic Colombel,

Millie D. Long, Hans H. Herfarth, Clare A. Pipkin, Carol Q

Volume 132, Issue 5, Pages (May 2007)

Volume 137, Issue 4, Pages (October 2009)

Volume 146, Issue 4, Pages e2 (April 2014)

Volume 154, Issue 6, Pages (May 2018)

Volume 132, Issue 1, Pages (January 2007)

Volume 133, Issue 6, Pages (December 2007)

Volume 135, Issue 5, Pages (November 2008)

Volume 138, Issue 5, Pages (May 2010)

Volume 133, Issue 2, Pages (August 2007)

Volume 150, Issue 5, Pages (May 2016)

Volume 149, Issue 6, Pages (November 2015)

Volume 150, Issue 7, Pages (June 2016)

Volume 145, Issue 5, Pages (November 2013)

Volume 136, Issue 7, Pages (June 2009)

The Rise and Fall (and Rise?) of Endoscopic Anti-Reflux Procedures

Diagnostic Colonoscopy: The End Is Coming

Correlation Between the Crohn's Disease Activity and Harvey–Bradshaw Indices in Assessing Crohn's Disease Severity Severine Vermeire, Stefan Schreiber,

Safety of Long-term Treatment With Certolizumab Pegol in Patients With Crohn's Disease, Based on a Pooled Analysis of Data From Clinical Trials Edward.

Covering the Cover Gastroenterology

The Dawning of a New Editorial Board for Gastroenterology

Volume 126, Issue 2, Pages (February 2004)

Volume 135, Issue 2, Pages (August 2008)

Reinduction With Certolizumab Pegol in Patients With Relapsed Crohn's Disease: Results From the PRECiSE 4 Study William J. Sandborn, Stefan Schreiber,

Richard J. Saad, William D. Chey Gastroenterology

Volume 151, Issue 4, Pages (October 2016)

Nicolas Williet, William J. Sandborn, Laurent Peyrin–Biroulet

Richard Blumberg, Judy Cho, James Lewis, Gary Wu Gastroenterology

Volume 156, Issue 4, Pages (March 2019)

Walter Reinisch, Jean-Frederic Colombel, William J

Volume 117, Issue 3, Pages (September 1999)

Changing of the Guards: 2011–2016 Gastroenterology Team

Volume 128, Issue 7, Pages (June 2005)

Volume 155, Issue 6, Pages (December 2018)

End-Stage Liver Disease in 2008: Finally a Glass Half Full

Volume 134, Issue 3, Pages (March 2008)

Controversies in Liver Transplantation for Hepatitis C

Medical Therapy for Refractory Pediatric Crohn’s Disease

Combination Therapy With Infliximab and Azathioprine Improves Infliximab Pharmacokinetic Features and Efficacy: A Post Hoc Analysis Jean-Frédéric Colombel,

Presentation transcript:

Volume 133, Issue 1, Pages 312-339 (July 2007) American Gastroenterological Association Consensus Development Conference on the Use of Biologics in the Treatment of Inflammatory Bowel Disease, June 21–23, 2006 Michael Clark, Jean-Frederic Colombel, Brian C. Feagan, Richard N. Fedorak, Stephen B. Hanauer, Michael A. Kamm, Lloyd Mayer, Carol Regueiro, Paul Rutgeerts, William J. Sandborn, Bruce E. Sands, Stefan Schreiber, Stephan Targan, Simon Travis, Severine Vermeire Gastroenterology Volume 133, Issue 1, Pages 312-339 (July 2007) DOI: 10.1053/j.gastro.2007.05.006 Copyright © 2007 AGA Institute Terms and Conditions

Figure 1 Design characteristics for biologic trials in CD. Gastroenterology 2007 133, 312-339DOI: (10.1053/j.gastro.2007.05.006) Copyright © 2007 AGA Institute Terms and Conditions

Figure 2 The learning curve of side effects. Gastroenterology 2007 133, 312-339DOI: (10.1053/j.gastro.2007.05.006) Copyright © 2007 AGA Institute Terms and Conditions